Rising levels of serum S100 protein precede other evidence of disease progression in patients with malignant melanoma
- 1 August 2000
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 143 (2) , 269-274
- https://doi.org/10.1046/j.1365-2133.2000.03650.x
Abstract
Background Several serum markers may be useful in the detection of metastatic melanoma, but none is in routine clinical use. Objective To assess the validity of S100 protein as a serum marker of me...Keywords
This publication has 7 references indexed in Scilit:
- Predictive value of serum S100B for monitoring patients with metastatic melanoma during chemotherapy and/or immunotherapyBritish Journal of Dermatology, 1999
- The luminescence immunoassay S-100: a sensitive test to measure circulating S-100B: its prognostic value in malignant melanomaBritish Journal of Cancer, 1998
- Serum S-100 protein: a potentially useful prognostic marker in cutaneous melanomaBritish Journal of Dermatology, 1997
- Elevated serum levels of S100 and survival in metastatic malignant melanomaBritish Journal of Cancer, 1997
- Serum S100 – A Marker for Disease Monitoring in Metastatic MelanomaDermatology, 1997
- Prognostic value of serum analyses of S-100β protein in malignant melanomaMelanoma Research, 1996